Orthofix Medical Inc. Q4 Loss Rises

Orthofix Medical

16.64 USD -2.66%

• Charts
• News
• Analysen

Kaufen Verkaufen

(RTTNews) - Orthofix Medical Inc. (OFIX) revealed Loss for its fourth quarter of -$29.147 million

The company's bottom line totaled -$29.147 million, or -$0.75 per share. This compares with -$22.174 million, or -$0.59 per share, last year.

The company's revenue for the period rose 7.6% to $215.657 million from $200.415 million last year.

Orthofix Medical Inc. earnings at a glance (GAAP) :

-Earnings: -$29.147 Mln. vs. -$22.174 Mln. last year. -EPS: -$0.75 vs. -$0.59 last year. -Revenue: $215.657 Mln vs. $200.415 Mln last year.

For the fourth quarter, the company posted adjusted income of $0.595 million, lower than $4.310 million, recorded for the same period last year.

Looking ahead, for the full-year 2025, Orthofix Medical expects sales of $818 to $826 million, excluding sales from the discontinued M6 artificial disc product lines and including a negative impact from foreign currency of around $4 million, or 50 basis points, on a reported basis, as compared with the full-year 2024.

For the full-year 2024, the company has registered sales of $799.491 million.

OFIX was down by 6.23 percent at $17.02 in the pre-market trade on the Nasdaq.